Tectonic Therapeutic | AVRO - Fremdkapital





Fremdkapital Veränderung Datum
Akebia Therapeutics USD 24.75M 11.64M 2026-06
Alnylam Pharmaceuticals USD 2.47B 6.56M 2026-06
Celltrion KRW 411.27B 998.23M 2026-03
Cspc Pharmaceutical CNY 180.69M 21.94M 2025-12
Deva Holding AS TRY 559.97M 44.39M 2023-09
Dianthus Therapeutics USD 0 0 2024-12
Divis Laboratories Ltd INR 50M 30M 2026-03
Gilead Sciences USD 20.86B 1.27B 2026-03
Ionis Pharmaceuticals USD 1.91B 6.62M 2026-06
Kangmei Pharma CNY 68.57M 9.87M 2026-03
Karyopharm Therapeutics USD 264.49M 13.73M 2026-03
Knight Therapeutics CAD 57.78M 26.92M 2025-12
Laboratorios Farma EUR 80.5M 28.26M 2024-12
MacroGenics USD 68.71M 1.29M 2026-03
Malin Corporation EUR 0 0 2024-12
Medical Developments International AUD 1.5M 167K 2025-12
Organigram Holdings CAD 60.76M 1.77M 2026-03
Ovoca Bio EUR 0 0 2021-06
Pfizer USD 60.5B 70M 2026-06
Pharma Mar EUR 32.13M 1.04M 2026-06
Qiagen NV USD 1.63B 19.45M 2026-06
Roche Holding CHF 25.22B 2.21B 2026-06
Sangamo BioSciences USD 0 0 2022-06
Sanofi EUR 14.65B 806M 2026-06
Sarepta Therapeutics USD 847.62M 9.46M 2026-06
Sartorius EUR 3.65B 311.1M 2026-06
Sino Biopharmaceutical CNY 3.08B 1B 2025-06
Takeda JPY 4.42T 50.32B 2026-06
Tilray USD 268.59M 3.82M 2025-09
Zealand Pharma A/S 307M 76.14M 2026-03
Zz Pientze Pharmaceu CNY 182.29M 4.27M 2026-03